News
RPHCF
15.20
NaN%
--
Rohto Pharmaceutical Completes Delayed Acquisition of Thann Oryza
TipRanks · 6d ago
Rohto Pharmaceutical Lowers Conversion Price on ¥25 Billion 2032 Convertible Bonds After Dividend
TipRanks · 05/21 07:02
Rohto Pharmaceutical Raises Dividend and Signals Further Payout Growth
TipRanks · 05/21 07:02
Rohto Board Rejects Shareholder Bid to Oust Veteran Director Kunio Yamada
TipRanks · 05/13 07:33
Rohto Pharmaceutical Lifts Dividend Forecast on Stronger Earnings Outlook
TipRanks · 05/13 07:33
Rohto Pharmaceutical Lifts Earnings, Strengthens Balance Sheet and Raises Dividend
TipRanks · 05/13 07:33
Rohto Faces Activist Shareholder Proposals Ahead of June Shareholders’ Meeting
TipRanks · 04/30 10:23
Rohto Pharmaceutical Launches ¥3 Billion Share Buyback to Boost Capital Efficiency
TipRanks · 03/26 07:00
Rohto Pharmaceutical Lifts Earnings Outlook and Hikes Dividend on Strong Overseas Performance
TipRanks · 02/12 08:11
Rohto Pharmaceutical Lifts Full-Year Outlook on Strong Nine-Month Earnings
TipRanks · 02/12 08:11
Rohto Pharmaceutical to Acquire Thailand’s THANN to Bolster Global Wellness Strategy
TipRanks · 01/07 06:55
Rohto Pharmaceutical Co (RPHCF) was upgraded to a Buy Rating at Jefferies
TipRanks · 12/24/2025 12:15
Rohto Pharmaceutical upgraded to Buy from Hold at Jefferies
TipRanks · 12/22/2025 09:45
Rohto Pharmaceutical upgraded to Buy from Hold at Jefferies
TipRanks · 12/19/2025 17:55
Rohto Pharmaceutical initiated with a Neutral at UBS
TipRanks · 12/14/2025 14:10
Rohto Pharmaceutical Reports Strong Growth in Latest Earnings
TipRanks · 11/14/2025 04:19
Rohto Pharmaceutical Acquires OBAGI Trademarks in Japan
TipRanks · 11/13/2025 07:20
Rohto Pharmaceutical Revises Earnings and Dividend Forecasts Upward
TipRanks · 11/13/2025 07:20
Rohto Pharmaceutical Reports Strong Financial Growth and Strategic Expansion
TipRanks · 11/13/2025 07:20
Rohto Pharmaceutical’s New Study: A Potential Game-Changer for Heart Disease Treatment?
TipRanks · 10/27/2025 21:23
More
Webull provides a variety of real-time RPHCF stock news. You can receive the latest news about Rohto Pha through multiple platforms. This information may help you make smarter investment decisions.
About RPHCF
Rohto Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of eye care (eye drops, eyewash), skin care (external medications, lip balm, sunscreen, functional cosmetics), oral medication (gastrointestinal medicines, herbal medicines, supplements), and other products and services (in vitro diagnostic reagents) in the health and beauty care field. The Company operates through four regional segments. The Japan segment manufactures and sells eye care, skin care, oral medication, and other products (services). The Americas segment and the Europe segment mainly manufacture and sell skin care products (services). The Asia segment mainly manufactures and sells eye care and skin care products (services), as well as oral medication products (services).